Catalyst
Slingshot members are tracking this event:
Phase 1 initial data of Bellicum's(BLCM) BPX-601 Pancreatic cancer due at ASCO June 1, 2019, 8am CT
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLCM | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 01, 2019
Occurred Source:
http://ir.bellicum.com/news-releases/news-release-details/bellicum-pharmaceuticals-provides-interim-data-bpx-601-patients
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bpx-601, Pancreatic Cancer, Phase 1
